Skip to Main Content

Paper Details

Response to "The Self-Controlled Case Series Design as a Viable Alternative to Studying Clinically Relevant Drug Interactions".
Clin Pharmacol Ther
1
2020
Author NameAffiliation
Joshua J GagneDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
  • 1 - 1

Datasets

Release 1.2